These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 19796683
1. Flowability characterisation of drug-excipient blends using a novel powder avalanching method. Nalluri VR, Kuentz M. Eur J Pharm Biopharm; 2010 Feb; 74(2):388-96. PubMed ID: 19796683 [Abstract] [Full Text] [Related]
2. Entrainment of lactose inhalation powders: a study using laser diffraction. Watling CP, Elliott JA, Cameron RE. Eur J Pharm Sci; 2010 Jul 11; 40(4):352-8. PubMed ID: 20417708 [Abstract] [Full Text] [Related]
9. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations. Marriott C, MacRitchie HB, Zeng XM, Martin GP. Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848 [Abstract] [Full Text] [Related]
10. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers. Zeng XM, MacRitchie HB, Marriott C, Martin GP. Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863 [Abstract] [Full Text] [Related]
11. Precipitated silica as flow regulator. Müller AK, Ruppel J, Drexel CP, Zimmermann I. Eur J Pharm Sci; 2008 Aug 07; 34(4-5):303-8. PubMed ID: 18595668 [Abstract] [Full Text] [Related]
16. Development of a novel approach towards predicting the milling behaviour of pharmaceutical powders. Kwan CC, Chen YQ, Ding YL, Papadopoulos DG, Bentham AC, Ghadiri M. Eur J Pharm Sci; 2004 Dec 07; 23(4-5):327-36. PubMed ID: 15567285 [Abstract] [Full Text] [Related]
17. Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance. Cordts E, Steckel H. Eur J Pharm Biopharm; 2012 Oct 07; 82(2):417-23. PubMed ID: 22902789 [Abstract] [Full Text] [Related]
19. Toward better understanding of powder avalanching and shear cell parameters of drug-excipient blends to design minimal weight variability into pharmaceutical capsules. Nalluri VR, Puchkov M, Kuentz M. Int J Pharm; 2013 Feb 14; 442(1-2):49-56. PubMed ID: 22917747 [Abstract] [Full Text] [Related]
20. Shear-induced APAP de-agglomeration. Llusa M, Levin M, Snee RD, Muzzio FJ. Drug Dev Ind Pharm; 2009 Dec 14; 35(12):1487-95. PubMed ID: 19929208 [Abstract] [Full Text] [Related] Page: [Next] [New Search]